The percentage of positive cells per all analyzed cells of 5.1% in ganglioneuroblastoma was lower than the 8.6% detected in a similar DIA in NSCLC 15, and the relevance of these values to guiding anti‐PD‐1/PD‐L1 immunotherapy development remains unknown. The gene discussed is CD274; the disease is ganglioneuroblastoma.